LifeMap Sciences’ Integrated Biomedical Knowledgebase and Premium Tools for Empowered life Sciences Research

LifeMap NGS Variant Gene Biological Interpretation & Prioritization

Rapid biological interpretation & prioritization of variant genes from next generation sequencing data using



Powered by the GeneCards Suite integrated biomedical knowledgebase

Learn More...

LifeMap RNAseq & Microarray Gene Set Analysis

Identify in seconds:

Cells, tissue types and various human diseases that match experimental gene sets - based on shared similar gene expression patterns.

Diseases, biological pathways and compounds that are associated with experimental gene sets - based on shared gene functionality. 


Powered by the GeneCards Suite integrated biomedical knowledgebase

Learn More...

GeneCards Suite Integrated Biomedical Knowledgebase

Effectively navigate the universe of biological entities - genes, proteins, cells, biological pathways and diseases, and the connections between them.

Learn More...


04 November 2015

LifeMap Sciences, a Subsidiary of BioTime, and Lab7 Systems Announce Partnership and Launch of Integrated NGS Analysis Solution

LifeMap Sciences, Inc. (“LifeMap”), a subsidiary of BioTime, Inc., and Lab7 Systems, Inc., announced today a partnership and launch of an integrated solution in the next-generation genomic sequencing (NGS) field, a multi-billion dollar, rapidly growing global market. LifeMap’s VarElect, The NGS Phenotyper, is now integrated into the Lab7 Enterprise Science Platform’s (ESP™) DNA sequence analysis, outputs and reports, enabling Lab7 ESP users to purchase access for enhanced variant gene prioritization and review of biological evidence linking variant genes to diseases and phenotypes of interest. Lab7 ESP, a solution for sample, data, and analysis management for NGS labs, supports life-science analytics at hospitals and medical research centers and organizations.

Read more
Featured Customers
LifeMap’s products are used in more than 3,000 institutions in academia, research hospitals, national patent offices, and leading biopharma and diagnostic companies, including: